PTCA    Immediate Angioplasty Versus Standard Therapy with Rescue Angioplasty after Thrombolysis in the Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction (Caress-in-Ami): An Open, Prospective, Randomised, Multicentre Trial Lancet (2008) 371;559-68 C. Di Mario, et al. Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice: The Sort out Ii Randomized Trial JAMA (2008) 299;409-16 A. M. Galloe, et al. Periprocedural Bleeding and 1-Year Outcome after Percutaneous Coronary Interventions: Appropriateness of Including Bleeding as a Component of a Quadruple End Point J Am Coll Cardiol (2008) 51;690-7 G. Ndrepepa, et al. Paclitaxel-Eluting Coronary Stents in Patients with Diabetes Mellitus: Pooled Analysis from 5 Randomized Trials J Am Coll Cardiol (2008) 51;708-15 A. J. Kirtane, et al. Direct Stenting for Stable Angina Pectoris Is Associated with Reduced Periprocedural Microcirculatory Injury Compared with Stenting after Pre-Dilation J Am Coll Cardiol (2008) 51;1060-5 T. Cuisset, et al. "Off-Label" Stent Therapy 2-Year Comparison of Drug-Eluting Versus Bare-Metal Stents J Am Coll Cardiol (2008) 51;607-14 R. J. Applegate, et al. Survival and Cardiac Remodeling Benefits in Patients Undergoing Late Percutaneous Coronary Intervention of the Infarct-Related Artery: Evidence from a Meta-Analysis of Randomized Controlled Trials J Am Coll Cardiol (2008) 51;956-64 A. Abbate, et al. Euroscore as Predictor of in-Hospital Mortality after Percutaneous Coronary Intervention Heart (2008) E. Romagnoli, et al. Two-Year Clinical Outcome after Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Diabetic Patients Eur Heart J (2008) 29;718-25 M. Billinger, et al. Optimal Medical Therapy with or without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (Courage) Trial Nuclear Substudy Circulation (2008) 117;1283-91 L. J. Shaw, et al. Two-Year Clinical Outcomes with Drug-Eluting Stents for Diabetic Patients with De Novo Coronary Lesions: Results from a Real-World Multicenter Registry Circulation (2008) 117;923-30 P. Ortolani, et al. Comparison of Coronary Artery Stenting Outcomes in the Eras before and after the Introduction of Drug-Eluting Stents Circulation (2008 E. L. Hannan, et al. Comparison of a Polymer-Free Rapamycin-Eluting Stent (Yukon) with a Polymer-Based Paclitaxel-Eluting Stent (Taxus) in Real-World Coronary Artery Lesions Catheter Cardiovasc Interv (2008) 71;333-9 J. Ruef, et al. Comparison of Five-Year Outcome in African Americans Versus Caucasians Following Percutaneous Coronary Intervention Catheter Cardiovasc Interv (2008) J. Pradhan, et al. Percutaneous Coronary Intervention Utilizing a New Endothelial Progenitor Cells Antibody-Coated Stent: A Prospective Single-Center Registry in High-Risk Patients Catheter Cardiovasc Interv (2008) 71;600-4 M. Miglionico, et al. Outcomes of Nonagenarians Who Undergo Percutaneous Coronary Intervention with Drug-Eluting Stents Catheter Cardiovasc Interv (2008) 71;526-30 M. S. Lee, et al Outcome of Intracoronary Stenting after Failed Maximal Medical Therapy in Patients with Symptomatic Myocardial Bridge Catheter Cardiovasc Interv (2008) 71;185-90 P. B. Kunamneni, et al Late Target Lesion Revascularization after Implantation of Sirolimus-Eluting Stent Catheter Cardiovasc Interv (2008) 71;299-303 M. K. Hong, et al. Novel Paclitaxel-Eluting, Biodegradable Polymer Coated Stent in the Treatment of De Novo Coronary Lesions: A Prospective Multicenter Registry Catheter Cardiovasc Interv (2008) 71;51-7 P. Buszman, et al Factors Associated with Off-Label Use of Drug-Eluting Stents in Patients with St-Elevation Myocardial Infarction Am J Cardiol (2008) 101;286-92 H. H. Ting, et al. Impact Of "Off-Label" Utilization of Drug-Eluting Stents on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention Am J Cardiol (2008) 101;293-9 P. Roy, et al. Long-Term (>3 Years) Outcome and Predictors of Clinical Events after Insertion of Sirolimus-Eluting Stent in One or More Native Coronary Arteries (from the Israeli Arm of the E-Cypher Registry) Am J Cardiol (2008) 101;953-9 D. Planer, et al. Four-Year Clinical Follow-up of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital Registry Am J Cardiol (2008) 101;1105-11 J. Daemen, et al. Clinical Outcomes after Heterogeneous Overlap Stenting with Drug-Eluting Stents and Bare-Metal Stents for De Novo Coronary Artery Narrowings Am J Cardiol (2008) 101;58-62 J. Aoki, et al. Drug-Eluting Stents in Octogenarians: Early and Intermediate Outcome Am Heart J (2008) 155;680-6 P. J. Vlaar, et al. Comparison of Vascular Response to Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent: Intravascular Ultrasound Results from Endeavor Iii Am Heart J (2008) 155;108-13 A. Miyazawa, et al. The Effect of Drug-Eluting Stents on Intermediate Angiographic and Clinical Outcomes in Diabetic Patients: Insights from Randomized Clinical Trials Am Heart J (2008) 155;640-7 D. J. Kumbhani, et al. Comparative Safety and Efficacy of a Sirolimus-Eluting Versus Paclitaxel-Eluting Stent: A Meta-Analysis Am Heart J (2008) 155;630-9 H. S. Gurm, et al. Use of Endothelial Progenitor Cell Capture Stent (Genous Bio-Engineered R Stent) During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: Intermediate- to Long-Term Clinical Follow-Up Am Heart J (2008) 155;128-32 M. Co, et al. Access Site Hematoma Requiring Blood Transfusion Predicts Mortality in Patients Undergoing Percutaneous Coronary Intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry Catheter Cardiovasc Interv (2007) 69;961-6 L. Yatskar, et al. An Evaluation of Octogenarians Undergoing Percutaneous Coronary Intervention from the Melbourne Interventional Group Registry Catheter Cardiovasc Interv (2007) 70;928-36 B. P. Yan, et al. Outcome in the Elderly Undergoing Percutaneous Coronary Intervention with Sirolimus-Eluting Stents: Results from the Prospective Multicenter German Cypher Stent Registry Heart J (2007) 154;682-7 M. Wiemer, et al. Randomized Trial of Rapamycin- and Paclitaxel-Eluting Stents with Identical Biodegradable Polymeric Coating and Design Eur Heart J (2007) 28;2720-5 R. Wessely, et al. The Cobalt Chromium Stent with Antiproliferative for Restenosis Ii (Costar Ii) Trial Study Design: Advancing the Active-Control Evaluation of Second-Generation Drug-Eluting Stents Am Heart J (2007) 153;743-8 T. Y. Wang, et al. Long-Term Clinical Outcomes and Thrombosis Rates of Sirolimus-Eluting Versus Paclitaxel-Eluting Stents in an Unselected Population with Coronary Artery Disease (Rewards Registry) Am J Cardiol (2007) 100;45-51 R. Waksman, et al. In Patients with St-Segment Elevation Myocardial Infarction with Cardiogenic Shock Treated with Percutaneous Coronary Intervention, Admission Glucose Level Is a Strong Independent Predictor for 1-Year Mortality in Patients without a Prior Diagnosis of Diabetes Am Heart J (2007) 154;1184-90 M. M. Vis, et al. The Impact of Chronically Diseased Coronary Arteries and Stenting on the Corrected Timi Frame Count in Elective Coronary Angiography and Percutaneous Coronary Intervention Procedures Catheter Cardiovasc Interv (2007) 70;691-700 K. Vijayalakshmi, et al. The Impact of Advanced Chronic Kidney Disease on in-Hospital Mortality Following Percutaneous Coronary Intervention for Acute Myocardial Infarction Catheter Cardiovasc Interv (2007) 70;701-5 S. Vasu, et al. Drug-Eluting Stents Show Delayed Healing: Paclitaxel More Pronounced Than Sirolimus Eur Heart J (2007) 28;974-9 H. M. van Beusekom, et al. Results of Percutaneous Coronary Interventions in Patients > or =90 Years of Age . Catheter Cardiovasc Interv (2007) 70;937-43 I. Teplitsky, et al. Risk Stratification for Patients Undergoing Nonurgent Percutaneous Coronary Intervention Using N-Terminal Pro-B-Type Natriuretic Peptide: A Clopidogrel for the Reduction of Events During Observation (Credo) Substudy Am Heart J (2007) 153;36-41 W. H. Tang, et al. Granulation Encapsulated Stent: A New Therapeutic Approach for Vascular Implantation Heart (2007) 93;238-43 L. Tang, et al. A Randomized Comparison of Sirolimus-Eluting Stent Implantation with Zotarolimus-Eluting Stent Implantation for the Treatment of Total Coronary Occlusions: Rationale and Design of the Primary Stenting of Occluded Native Coronary Arteries Iii (Prison Iii) Study Am Heart J (2007) 154;432-5 M. J. Suttorp and G. J. Laarman Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents N Engl J Med (2007) 356;998-1008 G. W. Stone, et al. Comparison of Effectiveness of Bare Metal Stents Versus Drug-Eluting Stents in Large (> or =3.5 Mm) Coronary Arteries Am J Cardiol (2007) 99;599-602 D. H. Steinberg, et al. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents N Engl J Med (2007) 356;989-97 C. Spaulding, et al. Cardiac Angiography in Renally Impaired Patients (Care) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Circulation (2007) 115;3189-96 R. J. Solomon, et al. Twenty-Five-Year Trends in in-Hospital and Long-Term Outcome after Percutaneous Coronary Intervention: A Single-Institution Experience Circulation (2007) 115;2835-41 M. Singh, et al. Debating the Risks of Drug-Eluting Stents N Engl J Med (2007) 356;325-8 M. Shuchman Steroid-Eluting Stents in Patients with Acute Coronary Syndrome: The Dexamethasone Eluting Stent Italian Registry Heart (2007) 93;598-600 F. Ribichini, et al. Drug-Eluting Stents Vs Bare Metal Stents for the Treatment of Large Coronary Vessels Am Heart J (2007) 154;373-8 A. R. Quizhpe, et al. Long-Term Follow-up of Drug-Eluting Stents When Inserted for on- and Off-Label Indications Am J Cardiol (2007) 100;1619-24 A. Qasim, et al. Differences in Mortality and Use of Revascularization in Black and White Patients with Acute Mi Admitted to Hospitals with and without Revascularization Services JAMA (2007) 297;2489-95 I. Popescu, et al. Percutaneous Coronary Intervention of Functionally Nonsignificant Stenosis: 5-Year Follow-up of the Defer Study J Am Coll Cardiol (2007) 49;2105-11 N. H. Pijls, et al. Drug-Eluting Stents for the Treatment of Bifurcation Lesions: A Randomized Comparison between Paclitaxel and Sirolimus Stents Am Heart J (2007) 153;15 e1-7 M. Pan, et al. Clinical Comparison Of "Normal-Hours" Vs "Off-Hours" Percutaneous Coronary Interventions for St-Elevation Myocardial Infarction Am Heart J (2007) 154;366-72 P. Ortolani, et al. Impact of Renal Insufficiency on Clinical and Angiographic Outcomes Following Percutaneous Coronary Intervention with Sirolimus-Eluting Stents Catheter Cardiovasc Interv (2007) 69;808-14 G. Nakazawa, et al. Comparison of Vascular Response to Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent: Intravascular Ultrasound Results from Endeavor Iii Am Heart J (2008) 155;108-13 A. Miyazawa, et al. Four-Year Clinical Follow-up after Implantation of the Endeavor Zotarolimus-Eluting Stent: Endeavor I, the First-in-Human Study Am J Cardiol (2007) 100;56M-61M I. T. Meredith, et al. Sex and Effect of Abciximab in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Interventions: Results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 Trial Am Heart J (2007) 154;158 e1-7 J. Mehilli, et al. Target Lesion Revascularisation in Patients Treated with a Sirolimus-Eluting or Paclitaxel-Eluting Stent Heart (2007) 93;694-7 M. Maeng, et al. Sirolimus-Eluting Stent Implantation for Treatment of Proximal Left Anterior Descending Coronary Artery Lesions: Long-Term Outcome and Predictors of Adverse Cardiac Events Catheter Cardiovasc Interv (2007) 70;368-73 C. W. Lee, et al. The Effect of Drug Eluting Stents on Cardiovascular Events in Patients with Intermediate Lesions and Borderline Fractional Flow Reserve Catheter Cardiovasc Interv (2007) 70;525-31 S. Lavi, et al. Long-Term Outcomes with Drug-Eluting Stents Versus Bare-Metal Stents in Sweden N Engl J Med (2007) 356;1009-19 B. Lagerqvist, et al. Early Invasive Versus Conservative Treatment in Patients with Failed Fibrinolysis--No Late Survival Benefit: The Final Analysis of the Middlesbrough Early Revascularisation to Limit Infarction (Merlin) Randomized Trial Am Heart J (2007) 153;763-71 B. Kunadian, et al. Comparison of Outcomes Using Sirolimus-Eluting Stenting in Diabetic Versus Nondiabetic Patients with Comparison of Insulin Versus Non-Insulin Therapy in the Diabetic Patients Am J Cardiol (2007) 100;1187-91 R. Kumar, et al. Quantitative Evaluation of Myocardial Blush to Assess Tissue Level Reperfusion in Patients with Acute St-Elevation Myocardial Infarction: Incremental Prognostic Value Compared with Visual Assessment Am Heart J (2007) 153;612-20 G. Korosoglou, et al. Randomized Comparison of Dexamethasone-Eluting Stents with Bare Metal Stent Implantation in Patients with Acute Coronary Syndrome: Serial Angiographic and Sonographic Analysis Am Heart J (2007) 153;979 e1-8 A. Konig, et al. The Truth and Consequences of the Courage Trial J Am Coll Cardiol (2007) 50;1598-603 D. J. Kereiakes, et al Feasibility of the Pci through 6f Diagnostic Catheters Catheter Cardiovasc Interv (2007) 69;410-5 P. F. Keller, et al. The Relationship between Coronary Plaque Characteristics and Small Embolic Particles During Coronary Stent Implantation J Am Coll Cardiol (2007) 50;1635-40 T. Kawamoto, et al. Reduction of Neointimal Hyperplasia after Coronary Stenting by Pioglitazone in Nondiabetic Patients with Metabolic Syndrome Am Heart J (2007) 153;762 e1-7 T. Katayama, et al. Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents N Engl J Med (2007) 356;1030-9 A. Kastrati, et al. Culotte Versus T-Stenting in Bifurcation Lesions: Immediate Clinical and Angiographic Results and Midterm Clinical Follow-Up Am Heart J (2007) 154;336-43 S. Kaplan, et al. Importance of Complete Revascularization in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention Am Heart J (2007) 153;304-12 Z. Kalarus, et al. Long-Term Clinical Benefit of Sirolimus-Eluting Stent Implantation in Diabetic Patients with De Novo Coronary Stenoses: Long-Term Results of the Diabetes Trial Eur Heart J (2007) 28;1946-52 P. Jimenez-Quevedo, et al. Real-World Safety and Efficacy of the Endeavor Zotarolimus-Eluting Stent: Early Data from the E-Five Registry J Cardiol (2007) 100;77M-83M A. K. Jain, et al. Impact of Late Incomplete Stent Apposition after Sirolimus-Eluting Stent Implantation on 4-Year Clinical Events. Intravascular Ultrasound Analysis from the Multicenter, Randomized, Ravel, E-Sirius and Sirius Trials Heart (2007) R. Hoffmann, et al. Randomized Trial Comparing Same-Day Discharge with Overnight Hospital Stay after Percutaneous Coronary Intervention: Results of the Elective Pci in Outpatient Study (Epos) Circulation (2007) 115;2299-306 G. S. Heyde, et al. The Cost-Effectiveness of an Early Interventional Strategy in Non-St-Elevation Acute Coronary Syndrome Based on the Rita 3 Trial Heart (2007) M. Henriksson, et al. Usefulness of Routine Unfractionated Heparin Infusion Following Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction in Patients Not Receiving Glycoprotein Iib/Iiia Inhibitors Am J Cardiol (2007) 99;202-7 K. J. Harjai, et al. A Comparison of Mortality, Myocardial Infarction, and Repeated Revascularization for Sirolimus-Eluting and Paclitaxel-Eluting Coronary Stents Am Heart J (2007) 154;545-53 E. L. Hannan, et al. Export Aspiration System in Patients with Acute Coronary Syndrome and Visible Thrombus Provides No Substantial Benefit Catheter Cardiovasc Interv (2007) 70;35-42 V. K. H, et al. Taxus Vi 2-Year Follow-Up: Randomized Comparison of Polymer-Based Paclitaxel-Eluting with Bare Metal Stents for Treatment of Long, Complex Lesions Eur Heart J (2007) 28;2578-82 E. Grube, et al. Utility of Three-Dimensional Reconstruction of Coronary Angiography to Guide Percutaneous Coronary Intervention Catheter Cardiovasc Interv (2007) 69;479-82 R. R. Gollapudi, et al. Comparison of Angiographically Guided Direct Stenting Technique with Direct Stenting and Optimal Balloon Angioplasty Guided with Intravascular Ultrasound. The Multicenter, Randomized Trial Results Am Heart J (2007) 154;669-75 R. J. Gil, et al. Effectiveness and Safety of the Sirolimus-Eluting Stents Coated with Bioabsorbable Polymer Coating in Human Coronary Arteries Catheter Cardiovasc Interv (2007) 69;198-202 J. Ge, et al. Comparison of Outcomes of Direct Stenting Versus Stenting after Balloon Predilation in Patients with Acute Myocardial Infarction (Dirami) Am J Cardiol (2007) 100;798-805 M. Gasior, et al. Relation of Plaque Size to Necrotic Core in the Three Major Coronary Arteries in Patients with Acute Coronary Syndrome as Determined by Intravascular Ultrasonic Imaging Radiofrequency Am J Cardiol (2007) 99;790-2 H. M. Garcia-Garcia, et al. Effects of Percutaneous Coronary Interventions in Silent Ischemia after Myocardial Infarction: The Swissi Ii Randomized Controlled Trial JAMA (2007) 297;1985-91 P. Erne, et al. Temporary Scaffolding of Coronary Arteries with Bioabsorbable Magnesium Stents: A Prospective, Non-Randomised Multicentre Trial Lancet (2007) 369;1869-75 R. Erbel, et al. Courage under Fire: On the Management of Stable Coronary Disease J Am Coll Cardiol (2007) 50;1604-9 G. A. Diamond and S. Kaul Incidence and Angiographic Predictors of Collateral Function in Patients with Stable Coronary Artery Disease Scheduled for Percutaneous Coronary Intervention Catheter Cardiovasc Interv (2007) 70;197-202 J. de Vries, et al. Comparison of Three-Year Clinical Outcome of Sirolimus- and Paclitaxel-Eluting Stents Versus Bare Metal Stents in Patients with St-Segment Elevation Myocardial Infarction (from the Research and T-Search Registries) Am J Cardiol (2007) 99;1027-32 J. Daemen, et al. The Long-Term Value of Sirolimus- and Paclitaxel-Eluting Stents over Bare Metal Stents in Patients with Diabetes Mellitus Eur Heart J (2007) 28;26-32 J. Daemen, et al. Outcome of Percutaneous Coronary Intervention in Hospitals with and without on-Site Cardiac Surgery Standby Heart (2007) 93;335-8 J. Carlsson, et al. Outcome of Overlapping Heterogenous Drug-Eluting Stents and of Overlapping Drug-Eluting and Bare Metal Stents Am J Cardiol (2007) 99;364-8 F. Burzotta, et al. Targeted Stent Use in Clinical Practice Based on Evidence from the Basel Stent Cost Effectiveness Trial (Basket) Eur Heart J (2007) 28;719-25 H. P. Brunner-La Rocca, et al. Cost-Effectiveness of Drug-Eluting Stents in Patients at High or Low Risk of Major Cardiac Events in the Basel Stent Kosteneffektivitats Trial (Basket): An 18-Month Analysis Lancet (2007) 370;1552-9 H. P. Brunner-La Rocca, et al. Safety of Drug-Eluting Stents in the Coronary Artery in St-Elevation Myocardial Infarction at a Single High-Volume Medical Center Am J Cardiol (2007) 100;949-52 R. Bose, et al. Optimal Medical Therapy with or without Pci for Stable Coronary Disease N Engl J Med (2007) 356;1503-16 W. E. Boden, et al. Apolipoprotein a-Ii Is Inversely Associated with Risk of Future Coronary Artery Disease Circulation (2007) 116;2029-35 R. S. Birjmohun, et al. Outcomes and Complications Associated with Off-Label and Untested Use of Drug-Eluting Stents JAMA (2007) 297;1992-2000 N. Beohar, et al. Stent Expansion: A Combination of Delivery Balloon Underexpansion and Acute Stent Recoil Reduces Predicted Stent Diameter Irrespective of Reference Vessel Size Heart (2007) 93;1562-6 S. Aziz, et al. Comparison of Drug-Eluting Versus Bare Metal Stents on Later Frequency of Acute Myocardial Infarction and Death Am J Cardiol (2007) 99;333-8 R. J. Applegate, et al Clinical Outcomes after Heterogeneous Overlap Stenting with Drug-Eluting Stents and Bare-Metal Stents for De Novo Coronary Artery Narrowings Am J Cardiol (2008) 101;58-62 J. Aoki, et al. Risk-Adjusted Mortality Analysis of Percutaneous Coronary Interventions by American College of Cardiology/American Heart Association Guidelines Recommendations Am J Cardiol (2007) 99;189-96 H. V. Anderson, et al. Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents Am J Cardiol (2007) 99;593-8 P. Agostoni, et al. Percutaneous Coronary Revascularization Using a Trilayer Metal Phosphorylcholine-Coated Zotarolimus-Eluting Stent Am J Cardiol (2007) 99;1403-8 A. Abizaid, et al. Unrestricted Use of Drug-Eluting Stents Compared with Bare-Metal Stents in Routine Clinical Practice: Findings from the National Heart, Lung, and Blood Institute Dynamic Registry J Am Coll Cardiol (2007) 50;2029-36 J. D. Abbott, et al. Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Am J Cardiol (2007) 99;626-31 J. D. Abbott, et al.